Drug interactions for the following drug(s)
Applies to: Prednisone 10 MG Oral Tablet <> Wellbutrin XL 300 MG 24 HR Extended Release Oral Tablet
Prednisone may decrease the excretion rate of Bupropion which could result in a higher serum level.
Applies to: Progesterone 100 MG Oral Capsule <> Wellbutrin XL 300 MG 24 HR Extended Release Oral Tablet
The metabolism of Progesterone can be decreased when combined with Bupropion.
Applies to: Prednisone 10 MG Oral Tablet <> Progesterone 100 MG Oral Capsule
The serum concentration of Prednisone can be increased when it is combined with Progesterone.
Applies to: Prednisone 10 MG Oral Tablet <> testosterone 1 % (50 MG / 5 GM) Transdermal Gel
The risk or severity of edema formation can be increased when Prednisone is combined with Testosterone propionate.
Applies to: Wellbutrin XL 300 MG 24 HR Extended Release Oral Tablet <> testosterone 1 % (50 MG / 5 GM) Transdermal Gel
The metabolism of Testosterone cypionate can be decreased when combined with Bupropion.
Applies to: testosterone 1 % (50 MG / 5 GM) Transdermal Gel <> Wellbutrin XL 300 MG 24 HR Extended Release Oral Tablet
Bupropion may decrease the excretion rate of Testosterone propionate which could result in a higher serum level.
Applies to: testosterone 1 % (50 MG / 5 GM) Transdermal Gel <> testosterone 1 % (50 MG / 5 GM) Transdermal Gel
Testosterone may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level.
Applies to: Progesterone 100 MG Oral Capsule <> testosterone 1 % (50 MG / 5 GM) Transdermal Gel
Progesterone may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: Prednisone 10 MG Oral Tablet <> Wellbutrin XL 300 MG 24 HR Extended Release Oral Tablet
Drug1 (rxcui = 198145, name = prednisone 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 993564, name = 24 HR bupropion hydrochloride 300 MG Extended Release Oral Tablet [Wellbutrin], tty = SBD). Drug1 is resolved to prednisone, Drug2 is resolved to bupropion and interaction asserted in DrugBank between Prednisone and Bupropion.
Applies to: Progesterone 100 MG Oral Capsule <> Wellbutrin XL 300 MG 24 HR Extended Release Oral Tablet
Drug1 (rxcui = 260243, name = progesterone 100 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 993564, name = 24 HR bupropion hydrochloride 300 MG Extended Release Oral Tablet [Wellbutrin], tty = SBD). Drug1 is resolved to progesterone, Drug2 is resolved to bupropion and interaction asserted in DrugBank between Progesterone and Bupropion.
Applies to: Prednisone 10 MG Oral Tablet <> Progesterone 100 MG Oral Capsule
Drug1 (rxcui = 198145, name = prednisone 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 260243, name = progesterone 100 MG Oral Capsule, tty = SCD). Drug1 is resolved to prednisone, Drug2 is resolved to progesterone and interaction asserted in DrugBank between Prednisone and Progesterone.
Applies to: Prednisone 10 MG Oral Tablet <> testosterone 1 % (50 MG / 5 GM) Transdermal Gel
Drug1 (rxcui = 198145, name = prednisone 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1597129, name = 5000 MG testosterone 0.01 MG/MG Topical Gel, tty = SCD). Drug1 is resolved to prednisone, Drug2 is resolved to testosterone propionate and interaction asserted in DrugBank between Prednisone and Testosterone propionate. Drug1 is resolved to prednisone, Drug2 is resolved to testosterone undecanoate and interaction asserted in DrugBank between Prednisone and Testosterone undecanoate. Drug1 is resolved to prednisone, Drug2 is resolved to testosterone cypionate and interaction asserted in DrugBank between Prednisone and Testosterone cypionate. Drug1 is resolved to prednisone, Drug2 is resolved to testosterone and interaction asserted in DrugBank between Prednisone and Testosterone. Drug1 is resolved to prednisone, Drug2 is resolved to testosterone enanthate and interaction asserted in DrugBank between Prednisone and Testosterone enanthate.
Applies to: Wellbutrin XL 300 MG 24 HR Extended Release Oral Tablet <> testosterone 1 % (50 MG / 5 GM) Transdermal Gel
Drug1 (rxcui = 993564, name = 24 HR bupropion hydrochloride 300 MG Extended Release Oral Tablet [Wellbutrin], tty = SBD). Drug2 (rxcui = 1597129, name = 5000 MG testosterone 0.01 MG/MG Topical Gel, tty = SCD). Drug1 is resolved to bupropion, Drug2 is resolved to testosterone cypionate and interaction asserted in DrugBank between Bupropion and Testosterone cypionate.
Applies to: testosterone 1 % (50 MG / 5 GM) Transdermal Gel <> Wellbutrin XL 300 MG 24 HR Extended Release Oral Tablet
Drug1 (rxcui = 1597129, name = 5000 MG testosterone 0.01 MG/MG Topical Gel, tty = SCD). Drug2 (rxcui = 993564, name = 24 HR bupropion hydrochloride 300 MG Extended Release Oral Tablet [Wellbutrin], tty = SBD). Drug1 is resolved to testosterone propionate, Drug2 is resolved to bupropion and interaction asserted in DrugBank between Testosterone propionate and Bupropion. Drug1 is resolved to testosterone undecanoate, Drug2 is resolved to bupropion and interaction asserted in DrugBank between Testosterone undecanoate and Bupropion. Drug1 is resolved to testosterone, Drug2 is resolved to bupropion and interaction asserted in DrugBank between Testosterone and Bupropion. Drug1 is resolved to testosterone enanthate, Drug2 is resolved to bupropion and interaction asserted in DrugBank between Testosterone enanthate and Bupropion.
Applies to: testosterone 1 % (50 MG / 5 GM) Transdermal Gel <> testosterone 1 % (50 MG / 5 GM) Transdermal Gel
Drug1 (rxcui = 1597129, name = 5000 MG testosterone 0.01 MG/MG Topical Gel, tty = SCD). Drug2 (rxcui = 1597129, name = 5000 MG testosterone 0.01 MG/MG Topical Gel, tty = SCD). Drug1 is resolved to testosterone, Drug2 is resolved to testosterone undecanoate and interaction asserted in DrugBank between Testosterone and Testosterone undecanoate. Drug1 is resolved to testosterone undecanoate, Drug2 is resolved to testosterone and interaction asserted in DrugBank between Testosterone undecanoate and Testosterone. Drug1 is resolved to testosterone propionate, Drug2 is resolved to testosterone enanthate and interaction asserted in DrugBank between Testosterone propionate and Testosterone enanthate. Drug1 is resolved to testosterone enanthate, Drug2 is resolved to testosterone propionate and interaction asserted in DrugBank between Testosterone enanthate and Testosterone propionate. Drug1 is resolved to testosterone propionate, Drug2 is resolved to testosterone cypionate and interaction asserted in DrugBank between Testosterone propionate and Testosterone cypionate. Drug1 is resolved to testosterone cypionate, Drug2 is resolved to testosterone propionate and interaction asserted in DrugBank between Testosterone cypionate and Testosterone propionate. Drug1 is resolved to testosterone, Drug2 is resolved to testosterone cypionate and interaction asserted in DrugBank between Testosterone and Testosterone cypionate. Drug1 is resolved to testosterone cypionate, Drug2 is resolved to testosterone and interaction asserted in DrugBank between Testosterone cypionate and Testosterone. Drug1 is resolved to testosterone, Drug2 is resolved to testosterone enanthate and interaction asserted in DrugBank between Testosterone and Testosterone enanthate. Drug1 is resolved to testosterone enanthate, Drug2 is resolved to testosterone and interaction asserted in DrugBank between Testosterone enanthate and Testosterone. Drug1 is resolved to testosterone, Drug2 is resolved to testosterone propionate and interaction asserted in DrugBank between Testosterone and Testosterone propionate. Drug1 is resolved to testosterone propionate, Drug2 is resolved to testosterone and interaction asserted in DrugBank between Testosterone propionate and Testosterone. Drug1 is resolved to testosterone enanthate, Drug2 is resolved to testosterone cypionate and interaction asserted in DrugBank between Testosterone enanthate and Testosterone cypionate. Drug1 is resolved to testosterone cypionate, Drug2 is resolved to testosterone enanthate and interaction asserted in DrugBank between Testosterone cypionate and Testosterone enanthate. Drug1 is resolved to testosterone enanthate, Drug2 is resolved to testosterone undecanoate and interaction asserted in DrugBank between Testosterone enanthate and Testosterone undecanoate. Drug1 is resolved to testosterone undecanoate, Drug2 is resolved to testosterone enanthate and interaction asserted in DrugBank between Testosterone undecanoate and Testosterone enanthate. Drug1 is resolved to testosterone undecanoate, Drug2 is resolved to testosterone cypionate and interaction asserted in DrugBank between Testosterone undecanoate and Testosterone cypionate. Drug1 is resolved to testosterone cypionate, Drug2 is resolved to testosterone undecanoate and interaction asserted in DrugBank between Testosterone cypionate and Testosterone undecanoate. Drug1 is resolved to testosterone propionate, Drug2 is resolved to testosterone undecanoate and interaction asserted in DrugBank between Testosterone propionate and Testosterone undecanoate. Drug1 is resolved to testosterone undecanoate, Drug2 is resolved to testosterone propionate and interaction asserted in DrugBank between Testosterone undecanoate and Testosterone propionate.
Applies to: Progesterone 100 MG Oral Capsule <> testosterone 1 % (50 MG / 5 GM) Transdermal Gel
Drug1 (rxcui = 260243, name = progesterone 100 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 1597129, name = 5000 MG testosterone 0.01 MG/MG Topical Gel, tty = SCD). Drug1 is resolved to progesterone, Drug2 is resolved to testosterone undecanoate and interaction asserted in DrugBank between Progesterone and Testosterone undecanoate. Drug1 is resolved to progesterone, Drug2 is resolved to testosterone and interaction asserted in DrugBank between Progesterone and Testosterone. Drug1 is resolved to progesterone, Drug2 is resolved to testosterone cypionate and interaction asserted in DrugBank between Progesterone and Testosterone cypionate. Drug1 is resolved to progesterone, Drug2 is resolved to testosterone enanthate and interaction asserted in DrugBank between Progesterone and Testosterone enanthate.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.